elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q34978329-57035403-203B-4BD9-A2EB-EE48939EC363
Q34978329-57035403-203B-4BD9-A2EB-EE48939EC363
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34978329-57035403-203B-4BD9-A2EB-EE48939EC363
Combination strategy targeting VEGF and HGF/c-met in human renal cell carcinoma models
P2860
Q34978329-57035403-203B-4BD9-A2EB-EE48939EC363
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34978329-57035403-203B-4BD9-A2EB-EE48939EC363
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
f5282b9a7507943a97b653294bf64206a3213d14
P2860
A phase I study of cabozantinib (XL184) in patients with renal cell cancer.